BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Increasing unusual put volume: MNDY BILI HWM SHW NVS AEP GRAB AXTX STT CAMT XEL TRIP ROST BCRX SBLK
• The Trade Desk (TTD) PT Raised to $14 at Evercore ISI